Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 106

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 106
---
.R. Section 200.83 The following table summarizes, on an adjusted pro forma basis as of December 31, 2024, the total number of shares of Class A Common Stock owned by existing stockholders and to be owned by new investors, the total consideration paid and the average price per share paid by our existing stockholders and to be paid by new investors in this offering at an assumed initial public offering price of $ per share (which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus), calculated before deduction of estimated underwriting discounts and commissions and estimated offering expenses payable by us:

|                                |     | Shares Acquired 
 Number          |     | Percent |     | Total Consideration 
 Amount              
 (in thousands)      |   |     | Percent |      |     | Average Price 
 Per Share     |   |
|:-------------------------------|:----|:----------------|:----|:--------|:----|:--------------------|:--|:----|:--------|:-----|:----|:--------------|:--|
| Existing stockholders          |     |                 |     | %       |     | $                   |   |     |         | %    |     | $             |   |
| New investors in this offering |     |                 |     | %       |     | $                   |   |     |         | %    |     | $             |   |
| Total                          |     |                 |     | 100%    |     |                     | $ |     |         | 100% |     |               | $ |

The above tables and discussion are based on the number of shares of our Class A Common Stock and Class B Common Stock to be outstanding as of the closing of this offering. If the underwriters’ option to purchase additional shares is exercised in full, the number of shares held by new investors will be increased to , or approximately % of the total number of shares of Class A Common Stock. 68

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION The unaudited pro forma condensed consolidated balance sheet as of December 31, 2024, and the unaudited pro forma condensed consolidated statement of operations for the year ended December 31, 2024, present our consolidated financial position and results of operations after giving effect to the following transactions (collectively, the “